Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Emerging Infectious Diseases|March 2, 2025
Identification of 2 Novel Species, Mycobacterium novusgordonae and M. shingordonaeKazuki Hashimoto, Yuko Abe, Kiyoharu Fukushima, et al.Cerebrovascular Diseases (Basel, Switzerland)|May 24, 2007
Carotid intima-media thickness and risk of cardiovascular events in high-risk patients. Results of the Osaka Follow-Up Study for Carotid Atherosclerosis 2 (OSACA2 Study)Kazuo Kitagawa, Hidetaka Hougaku, Hiroshi Yamagami, et al.Cancer Immunology, Immunotherapy : CII|October 17, 2021
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transferMiho Takahashi, Satoshi Watanabe, Ryo Suzuki, et al.Journal of Clinical Microbiology|March 22, 2023
MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective StudyKiyoharu Fukushima, Yuki Matsumoto, Takanori Matsuki, et al.Pigment Cell & Melanoma Research|June 20, 2020
Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukodermaKen Okamura, Yuko Abe, Izumi Naka, et al.Scientific Reports|January 13, 2021
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicityMasashi Arita, Satoshi Watanabe, Nobumasa Aoki, et al.Antimicrobial Agents and Chemotherapy|October 8, 2024
Variability of macrolide-resistant profile in <i>Mycobacterium avium</i> complex pulmonary diseaseKiyoharu Fukushima, Yuki Matsumoto, Yuko Abe, et al.Emerging Infectious Diseases|June 22, 2022
Chronic Pulmonary Disease Caused by Tsukamurella toyonakaenseTomoki Kuge, Kiyoharu Fukushima, Yuki Matsumoto, et al.International Immunology|April 24, 2026
Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosisHiroshi Nabeshima, Kiyoharu Fukushima, Yu-Chen Liu, et al.Respiratory Research|April 24, 2025
Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung diseaseTakatoshi Enomoto, Yoshito Takeda, Yuya Shirai, et al.Pageof 11